ID   UCRU-BL-28
AC   CVCL_4904
SY   UCRU-BL 28; BL-28; BL28; Urological Cancer Research Unit-BLadder-28
DR   Cosmic; 735774
DR   Cosmic; 928829
DR   Cosmic; 1927312
DR   Wikidata; Q54989704
RX   PubMed=8345582;
RX   PubMed=8873383;
RX   PubMed=9246190;
RX   PubMed=23401075;
CC   Misspelling: BL-128; Cosmic=1927312.
CC   Misspelling: BL128; PubMed=23401075.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
RX   PubMed=8345582; DOI=10.1016/S0022-5347(17)35682-3;
RA   Russell P.J., Palavidis Z., Rozinova E., Philips J., Wills E.J.,
RA   Lukeis R., Wass J., Raghavan D.;
RT   "Characterization of a new human bladder cancer cell line, UCRU-BL-28.";
RL   J. Urol. 150:1038-1044(1993).
//
RX   PubMed=8873383; DOI=10.1007/BF00295899;
RA   Stadler W.M., Olopade O.I.;
RT   "The 9p21 region in bladder cancer cell lines: large homozygous
RT   deletion inactivate the CDKN2, CDKN2B and MTAP genes.";
RL   Urol. Res. 24:239-244(1996).
//
RX   PubMed=9246190; DOI=10.1080/09553009714349;
RA   Ribeiro J.C.C., Barnetson A.R., Fisher R.J., Mameghan H., Russell P.J.;
RT   "Relationship between radiation response and p53 status in human
RT   bladder cancer cells.";
RL   Int. J. Radiat. Biol. 72:11-20(1997).
//
RX   PubMed=23401075; DOI=10.1002/path.4176;
RA   Guo Y.-N., Chekaluk Y., Zhang J.-M., Du J.-Y., Gray N.S., Wu C.-L.,
RA   Kwiatkowski D.J.;
RT   "TSC1 involvement in bladder cancer: diverse effects and therapeutic
RT   implications.";
RL   J. Pathol. 230:17-27(2013).
//